Guardant Health Inc (NASDAQ:GH) has a beta value of 1.15 and has seen 0.56 million shares traded in the recent trading session. The company, currently valued at $3.74B, closed the recent trade at $30.40 per share which meant it lost -$0.07 on the day or -0.23% during that session. The GH stock price is -35.07% off its 52-week high price of $41.06 and 47.99% above the 52-week low of $15.81. If we look at the company’s 10-day average daily trading volume, we find that it stood at 3.33 million shares traded. The 3-month trading volume is 2.31 million shares.
The consensus among analysts is that Guardant Health Inc (GH) is Buy stock at the moment, with a recommendation rating of 1.29. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 13 have rated it as a Hold, with 13 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.74.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Guardant Health Inc (NASDAQ:GH) trade information
Sporting -0.23% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the GH stock price touched $30.40 or saw a rise of 11.4%. Year-to-date, Guardant Health Inc shares have moved 12.38%, while the 5-day performance has seen it change -5.47%. Over the past 30 days, the shares of Guardant Health Inc (NASDAQ:GH) have changed -3.61%. Short interest in the company has seen 6.99 million shares shorted with days to cover at 4.27.
Wall Street analysts have a consensus price target for the stock at $42.5, which means that the shares’ value could jump 28.47% from the levels at last check today. The projected low price target is $36.0 while the price target rests at a high of $125.0. In that case, then, we find that the latest price level in today’s session is -311.18% off the targeted high while a plunge would see the stock gain -18.42% from the levels at last check today.
Guardant Health Inc (GH) estimates and forecasts
Figures show that Guardant Health Inc shares have outperformed across the wider relevant industry. The company’s shares have gained 34.45% over the past 6 months, with this year growth rate of 49.53%, compared to 17.10% for the industry. Revenue growth from the last financial year stood is estimated to be 22.60%.
21 analysts offering their estimates for the company have set an average revenue estimate of 170.55M for the current quarter. 21 have an estimated revenue figure of 180.39M for the next ending quarter. Year-ago sales stood 143.03M and 155.05M respectively for this quarter and the next, and analysts expect sales will grow by 19.20% for the current quarter and 22.60% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -8.88% over the past 5 years. Earnings growth for 2024 is a modest 23.78% while over the next 5 years, the company’s earnings are expected to increase by 29.20%.
GH Dividends
Guardant Health Inc is expected to release its next earnings report 2024-Nov-04 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Guardant Health Inc (NASDAQ:GH)’s Major holders
Insiders own 4.55% of the company shares, while shares held by institutions stand at 96.70% with a share float percentage of 101.31%. Investors are also buoyed by the number of investors in a company, with Guardant Health Inc having a total of 393.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 11.44 million shares worth more than $235.93 million. As of 2024-03-31, VANGUARD GROUP INC held 10.2118% of shares outstanding.
The other major institutional holder is BLACKROCK INC., with the holding of over 11.01 million shares as of 2024-03-31. The firm’s total holdings are worth over $227.22 million and represent 9.8349% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard U.S. Growth Fund. As of Mar 31, 2024, the former fund manager holds about 2.87% shares in the company for having 3.53 shares of worth $107.29 million while later fund manager owns 3.14 shares of worth $95.47 million as of May 31, 2024, which makes it owner of about 2.55% of company’s outstanding stock.
